854
Views
4
CrossRef citations to date
0
Altmetric
Neurotherapeutics

Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States

, , , , &
Pages 585-592 | Received 13 Oct 2017, Accepted 27 Nov 2017, Published online: 08 Dec 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.